1.A Case of Gastric Metastasis from Breast Carcinoma Manifested by Upper Gastrointestinal Bleeding.
Sang Hoon JEON ; Yoong Seog LEE ; Taek Kun KWON ; Sang Hyun KIM ; Du Young KWON ; Kyung Sik PARK ; Jun Young HWANG ; Kwang Bum CHO ; Jae Seok HWANG ; Sung Hoon AHN ; Soong Kook PARK
Korean Journal of Gastrointestinal Endoscopy 2002;24(4):220-224
Breast carcinoma is common malignancy in women and frequently metastasize to multiple organ such as lung, bone, lymph node and liver. But metastasis to gastrointestinal tract is rare and only two cases have been reported in Korea. We experienced a case of upper gastrointestinal bleeding caused by gastric metastasis from ductal carcinoma of breast and report this case with review of several literatures.
Breast Neoplasms*
;
Breast*
;
Carcinoma, Ductal
;
Female
;
Gastrointestinal Tract
;
Hemorrhage*
;
Humans
;
Korea
;
Liver
;
Lung
;
Lymph Nodes
;
Neoplasm Metastasis*
2.The Effect of Intensified Induction Using Vanderbilt Regimen in Patients with an Intermediate Grade Non-Hodgkin's Lymphoma Having 2 or 3 Adverse Factors on the Age-adjusted International Prognostic Index.
Yoong Ju KWEON ; Seong Jun CHOI ; Baek Yeol RYOO ; Yeon Hee PARK ; Bong Seog KIM ; Dae Han KIM ; Sang Il KIM ; Sung Ho KIM ; Yo Ahn SUH ; Hyun Bae SON ; Kui Sung CHOI ; Seung Sook LEE ; Yoon Koo KANG
Cancer Research and Treatment 2002;34(5):326-333
PURPOSE: The purpose of our study was to evaluate the outcome of intensified induction therapy using the Vanderbilt regimen in patients with a poor prognosis non-Hodgkin's lymphoma (NHL). MATERIALS AND METHODS: We retrospectively analyzed the results of two pilot studies, which enrolled the patients aged 60 years or less, with a previously untreated NHL of intermediate grade on the Working formulation, having 2 or 3 adverse prognostic factors on the age- adjusted International Prognostic Index. Patients received an intensified induction, with the regimen described by the Vanderbilt group. RESULTS: Thirty-five patients were analyzed. After induction, 29 patients (83%) achieved more than partial response (PR): 22 (63%) complete response (CR) and 7 (20%) PR. Three of the PRs were subsequently converted to CR following consolidation therapy. The overall CR rate, following the completion of treatment, was 71%. The 3-year overall survival (OS) rate of all patients was 53%. In the univariate analysis, age (
Bone Marrow
;
Cohort Studies
;
Disease-Free Survival
;
Drug Therapy
;
Heart Failure
;
Humans
;
Lymphoma, Non-Hodgkin*
;
Pilot Projects
;
Prognosis
;
Retrospective Studies
;
Sepsis